Cargando…
Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups
BACKGROUND: Lipid-based formulations of amphotericin B (LF-AMB) are indicated for treatment of invasive fungal infections in patients intolerant to conventional amphotericin B (CAB) or with refractory infections. Physicians still may choose to administer CAB to such patients. We described the use of...
Autores principales: | Campbell, Rebecca S, Chaudhari, Paresh, Hays, Harlen D, Taylor, Robert J, Nathanson, Brian H, Bozzette, Samuel A, Horn, David L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810329/ https://www.ncbi.nlm.nih.gov/pubmed/24187506 http://dx.doi.org/10.2147/CEOR.S46834 |
Ejemplares similares
-
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections
por: Zilberberg, Marya D, et al.
Publicado: (2012) -
Amphotericin B lipid formulations and target-site penetration into human body fluids
por: Weiler, Stefan, et al.
Publicado: (2008) -
Robot-assisted vs. conventional MIDCAB: A propensity-matched analysis
por: Gofus, Jan, et al.
Publicado: (2022) -
Propensity score matching with R: conventional methods and new features
por: Zhao, Qin-Yu, et al.
Publicado: (2021) -
Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)